Teva stock climbs past $30 with strong Austedo and Ajovy sales, but shifting Wall Street sentiment may affect its outlook.
The Wegovy pill's approval signifies a shift from injectable to oral dosage forms, driven by patient preference for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback